Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer NCT04751747 Locally Advance...
Metastatic Lung...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Computed Tomogr...
Contrast Agent
18 Years - Rutgers, The State University of New Jersey View Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer NCT05045404 Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Poziotinib Hydr...
1429757-68-5, H...
18 Years - M.D. Anderson Cancer Center View EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer NCT05498389 Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd. View Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer NCT03707938 Advanced Lung C...
ALK Gene Rearra...
Lung Non-Small ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Brigatinib
Local Consolida...
18 Years - M.D. Anderson Cancer Center View Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy NCT03965689 Metastatic Lung...
Metastatic Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Carboplatin
Paclitaxel
Pevonedistat
18 Years - National Cancer Institute (NCI) View 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267 Anatomic Stage ...
Clinical Stage ...
Glioma
Malignant Brain...
Metastatic Brea...
Metastatic Colo...
Metastatic Kidn...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Pathologic Stag...
Prognostic Stag...
Stage IV Colon ...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Lung ...
Stage IVB Colon...
Stage IVB Lung ...
Stage IVC Colon...
Computed Tomogr...
18F-FMAU
Multiparametric...
Positron Emissi...
18 Years - University of Southern California View Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer NCT04073745 Lung Non-Small ...
Positive Surgic...
Resected Mass
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Quality-of-Life...
Questionnaire A...
Stereotactic Bo...
18 Years - Roswell Park Cancer Institute View Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial NCT05339022 Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center View Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer NCT05017025 Advanced Lung N...
Metastatic Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Aurora A Kinase...
Osimertinib
18 Years - M.D. Anderson Cancer Center View 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis NCT00862680 Metastatic Mali...
Metastatic Mali...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
4-Dimensional C...
4D PET Scan
18 Years - M.D. Anderson Cancer Center View Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer NCT03944265 Activating ALK ...
Activating EGFR...
Activating ROS1...
Health Care Pro...
Lung Non-Small ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Counseling
Questionnaire A...
Medical Chart R...
18 Years - Thomas Jefferson University View Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies NCT02419495 Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Fallopian Tube ...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Ovarian Carcino...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Primary Periton...
Stage III Lung ...
Stage III Renal...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Triple-Negative...
Unresectable Lu...
Unresectable Me...
Unresectable Re...
Capecitabine
Carboplatin
Cyclophosphamid...
Doxorubicin
Eribulin
Fluorouracil
Ipilimumab
Irinotecan Hydr...
Leucovorin Calc...
Nivolumab
Olaparib
Oxaliplatin
Paclitaxel
Pembrolizumab
Pemetrexed
Selinexor
Topotecan
18 Years - M.D. Anderson Cancer Center View A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer NCT05342571 Advanced Lung C...
Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Behavioral, Psy...
Biospecimen Col...
Electronic Heal...
Informational I...
Survey Administ...
18 Years - Ohio State University Comprehensive Cancer Center View Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability NCT04804644 Metastatic Lung...
Metastatic Mali...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine Hydro...
Neurocognitive ...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology View Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery NCT04588246 Anatomic Stage ...
Metastatic Brea...
Metastatic Dige...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Prognostic Stag...
Recurrent Brain...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine
Quality-of-Life...
Questionnaire A...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology View Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054 Stage III Cutan...
Stage IV Cutane...
Locally Advance...
Locally Advance...
Metastatic Head...
Metastatic Mali...
Metastatic Mela...
Metastatic Urot...
Non-Small Cell ...
Stage IB Lung C...
Stage III Cutan...
Stage III Lung ...
Stage III Urete...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Cutane...
Stage IV Lung C...
Stage IV Ureter...
Stage IVA Lung ...
Stage IVB Lung ...
Abexinostat
Pembrolizumab
18 Years - University of California, San Francisco View Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) NCT04625647 Lung Adenocarci...
Lung Non-Small ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Sotorasib
18 Years - SWOG Cancer Research Network View Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520 Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Mali...
Metastatic Mela...
Metastatic Prim...
Metastatic Sarc...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Prognostic Stag...
Prognostic Stag...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Avapritinib
18 Years - M.D. Anderson Cancer Center View Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer NCT04120454 Metastatic Lung...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Pembrolizumab
Ramucirumab
18 Years - Ohio State University Comprehensive Cancer Center View Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study NCT04430725 Lung Non-Small ...
Metastatic Colo...
Metastatic Sarc...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Computed Tomogr...
Microwave Ablat...
Questionnaire A...
Wedge Excision
18 Years - M.D. Anderson Cancer Center View Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer NCT05364645 Lung Non-Small ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Pemetrexed
Selpercatinib
18 Years - SWOG Cancer Research Network View Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer NCT03737994 Lung Non-Squamo...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Alectinib
Brigatinib
Carboplatin
Ceritinib
Cisplatin
Crizotinib
Ensartinib
Lorlatinib
Pemetrexed
18 Years - National Cancer Institute (NCI) View Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery NCT04588246 Anatomic Stage ...
Metastatic Brea...
Metastatic Dige...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Prognostic Stag...
Recurrent Brain...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine
Quality-of-Life...
Questionnaire A...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology View Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial NCT05161533 Extensive Stage...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Cisplatin
Durvalumab
Etoposide
Hypofractionate...
Quality-of-Life...
Questionnaire A...
18 Years - University of Washington View Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer NCT02983578 Advanced Colore...
Advanced Lung N...
Lung Non-Small ...
Mismatch Repair...
Refractory Colo...
Refractory Lung...
Refractory Panc...
Stage II Pancre...
Stage III Color...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IV Pancre...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Danvatirsen
Durvalumab
18 Years - M.D. Anderson Cancer Center View Resiliency Among Older Adults Receiving Lung Cancer Treatment NCT04229381 Advanced Lung C...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center View Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer NCT05340309 Lung Non-Small ...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Atezolizumab an...
Survey Administ...
18 Years - University of Southern California View Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers NCT03948100 Esophageal Carc...
Lung Non-Small ...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
Quality-of-Life...
Questionnaire A...
Yoga
18 Years - M.D. Anderson Cancer Center View Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer NCT05493566 Lung Non-Small ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Aldesleukin
Pembrolizumab
18 Years - Emory University View Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study NCT03707574 Advanced Malign...
Advanced Melano...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Lung ...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Lung ...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
18 Years - National Cancer Institute (NCI) View PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer NCT05234307 Metastatic Lung...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Adenosine A2B R...
Biospecimen Col...
Nivolumab
18 Years - Ohio State University Comprehensive Cancer Center View Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer NCT03707938 Advanced Lung C...
ALK Gene Rearra...
Lung Non-Small ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Brigatinib
Local Consolida...
18 Years - M.D. Anderson Cancer Center View Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer NCT04285671 Metastatic Lung...
Refractory Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Necitumumab
Osimertinib
Quality-of-Life...
Questionnaire A...
Trastuzumab
18 Years - Jonsson Comprehensive Cancer Center View Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer NCT04479306 Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Alisertib
Osimertinib
Sapanisertib
18 Years - M.D. Anderson Cancer Center View Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers NCT03902535 Caregiver
Head and Neck C...
Lung Carcinoma
Metastatic Head...
Metastatic Lung...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Comprehensive G...
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center View Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer NCT03707938 Advanced Lung C...
ALK Gene Rearra...
Lung Non-Small ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Brigatinib
Local Consolida...
18 Years - M.D. Anderson Cancer Center View Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related Fatigue NCT05407038 Advanced Lung N...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Exercise Counse...
Exercise Interv...
Internet-Based ...
Interview
Medical Device ...
Questionnaire A...
18 Years - Mayo Clinic View Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer NCT04919382 Extensive Stage...
Metastatic Lung...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Atezolizumab
Temozolomide
18 Years - Big Ten Cancer Research Consortium View Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors NCT02589522 Metastatic Lung...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Berzosertib
Quality-of-Life...
Therapeutic Con...
Whole-Brain Rad...
18 Years - National Cancer Institute (NCI) View Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma NCT04940299 Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Solid...
Metastatic Blad...
Metastatic Blad...
Metastatic Lung...
Metastatic Mela...
Metastatic Rena...
Metastatic Uret...
Metastatic Uret...
Metastatic Uret...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Me...
Ipilimumab
Nivolumab
Tocilizumab
18 Years - M.D. Anderson Cancer Center View Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis NCT04516070 Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Stereotactic Ra...
18 Years - M.D. Anderson Cancer Center View Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade NCT04340882 Metastatic Non-...
Recurrent Non-S...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Docetaxel
Pembrolizumab
Ramucirumab
18 Years - Emory University View Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer NCT03995667 Extensive Stage...
Limited Stage L...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Tumor Treating ...
22 Years - OHSU Knight Cancer Institute View Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors NCT05334329 Advanced Lung N...
Metastatic Lung...
Recurrent Lung ...
Refractory Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Antineoplastic ...
Atezolizumab
Biospecimen Col...
Cyclophosphamid...
Fludarabine
18 Years - City of Hope Medical Center View 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis NCT00862680 Metastatic Mali...
Metastatic Mali...
Stage IV Colore...
Stage IV Lung C...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
4-Dimensional C...
4D PET Scan
18 Years - M.D. Anderson Cancer Center View Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer NCT03995667 Extensive Stage...
Limited Stage L...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Tumor Treating ...
22 Years - OHSU Knight Cancer Institute View A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer NCT05342571 Advanced Lung C...
Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Behavioral, Psy...
Biospecimen Col...
Electronic Heal...
Informational I...
Survey Administ...
18 Years - Ohio State University Comprehensive Cancer Center View Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer NCT04971187 Locally Advance...
Metastatic Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Bintrafusp Alfa
Pemetrexed
Carboplatin
Cisplatin
18 Years - M.D. Anderson Cancer Center View Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC NCT04227028 Locally Advance...
Metastatic Lung...
Recurrent Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Bevacizumab
Brigatinib
18 Years - City of Hope Medical Center View Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Colitis
Lung Non-Small ...
Malignant Genit...
Malignant Solid...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Best Practice
Biospecimen Col...
Endoscopic Proc...
Fecal Microbiot...
Infliximab
Laboratory Biom...
Prednisone
Vedolizumab
18 Years - M.D. Anderson Cancer Center View EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer NCT05498389 Metastatic Lung...
Advanced Lung N...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
EGFR Mutation-R...
EMB-01
Osimertinib
18 Years - Shanghai EpimAb Biotherapeutics Co., Ltd. View Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial NCT04728230 Extensive Stage...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Durvalumab
Etoposide
Olaparib
Radiation Thera...
18 Years - M.D. Anderson Cancer Center View Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer NCT04262869 Lung Non-Small ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Durvalumab
Paclitaxel
Pemetrexed
18 Years - Emory University View Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) NCT04267913 Lung Squamous C...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Dexamethasone
Docetaxel
Ramucirumab
Sapanisertib
- SWOG Cancer Research Network View Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies NCT04902040 Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center View Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial NCT04728230 Extensive Stage...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Durvalumab
Etoposide
Olaparib
Radiation Thera...
18 Years - M.D. Anderson Cancer Center View 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267 Anatomic Stage ...
Clinical Stage ...
Glioma
Malignant Brain...
Metastatic Brea...
Metastatic Colo...
Metastatic Kidn...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Pathologic Stag...
Prognostic Stag...
Stage IV Colon ...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Colon...
Stage IVA Lung ...
Stage IVB Colon...
Stage IVB Lung ...
Stage IVC Colon...
Computed Tomogr...
18F-FMAU
Multiparametric...
Positron Emissi...
18 Years - University of Southern California View Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial NCT05339022 Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center View Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer NCT03944265 Activating ALK ...
Activating EGFR...
Activating ROS1...
Health Care Pro...
Lung Non-Small ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Counseling
Questionnaire A...
Medical Chart R...
18 Years - Thomas Jefferson University View Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies NCT04902040 Advanced Bladde...
Advanced Lung N...
Advanced Malign...
Advanced Melano...
Advanced Merkel...
Advanced Renal ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage III Bladd...
Stage III Lung ...
Stage III Renal...
Stage IIIA Blad...
Stage IIIA Lung...
Stage IIIB Blad...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Bladde...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Bladd...
Stage IVA Lung ...
Stage IVB Bladd...
Stage IVB Lung ...
Atezolizumab
Avelumab
Durvalumab
Nivolumab
Pembrolizumab
Plinabulin
Radiation Thera...
18 Years - M.D. Anderson Cancer Center View Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability NCT04804644 Metastatic Lung...
Metastatic Mali...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine Hydro...
Neurocognitive ...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology View Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial NCT04728230 Extensive Stage...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Durvalumab
Etoposide
Olaparib
Radiation Thera...
18 Years - M.D. Anderson Cancer Center View Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study NCT05022394 Lung Non-Small ...
Recurrent Lung ...
Stage I Lung Ca...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Nivolumab
Sapanisertib
18 Years - M.D. Anderson Cancer Center View Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial NCT05161533 Extensive Stage...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Carboplatin
Cisplatin
Durvalumab
Etoposide
Hypofractionate...
Quality-of-Life...
Questionnaire A...
18 Years - University of Washington View Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer NCT05045404 Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Poziotinib Hydr...
1429757-68-5, H...
18 Years - M.D. Anderson Cancer Center View Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment NCT03731585 Non-Small Cell ...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Behavioral Inte...
Educational Int...
Questionnaire A...
Support Group T...
18 Years - M.D. Anderson Cancer Center View Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial NCT05339022 Advanced Lung N...
Advanced Lung S...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Best Practice
Exercise Interv...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center View Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity NCT04954885 Lung Non-Squamo...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Biospecimen Col...
Physical Perfor...
Physical Perfor...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center View Resiliency Among Older Adults Receiving Lung Cancer Treatment NCT04229381 Advanced Lung C...
Extensive Stage...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Unresectable Lu...
Unresectable Lu...
Physical Therap...
Quality-of-Life...
Questionnaire A...
Relaxation Ther...
60 Years - Ohio State University Comprehensive Cancer Center View Family Caregivers in Underserved Populations Providing Complex Cancer Care NCT05213078 Malignant Femal...
Stage 0 Lung Ca...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Lung C...
Stage IIA Lung ...
Stage IIB Lung ...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
Quality-of-Life...
Questionnaire A...
18 Years - City of Hope Medical Center View A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer NCT05215769 Anatomic Stage ...
Metastatic Brea...
Metastatic Lung...
Metastatic Mali...
Prognostic Stag...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Health Educatio...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center View Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery NCT04588246 Anatomic Stage ...
Metastatic Brea...
Metastatic Dige...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Prognostic Stag...
Recurrent Brain...
Stage IV Lung C...
Stage IV Renal ...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine
Quality-of-Life...
Questionnaire A...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology View Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer NCT04533451 Metastatic Lung...
Metastatic Lung...
Recurrent Lung ...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Pembrolizumab
Pemetrexed
Carboplatin
Comprehensive G...
Questionnaire A...
Quality-of-Life...
70 Years - Alliance for Clinical Trials in Oncology View Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors NCT05334329 Advanced Lung N...
Metastatic Lung...
Recurrent Lung ...
Refractory Lung...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Antineoplastic ...
Atezolizumab
Biospecimen Col...
Cyclophosphamid...
Fludarabine
18 Years - City of Hope Medical Center View Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer NCT04479306 Recurrent Lung ...
Stage IIIB Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Alisertib
Osimertinib
Sapanisertib
18 Years - M.D. Anderson Cancer Center View CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer NCT03546361 Lung Non-Small ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Autologous Dend...
Pembrolizumab
18 Years - Jonsson Comprehensive Cancer Center View Bronchoscopic Laser Ablation of Peripheral Lung Tumors NCT03707925 Lung Carcinoid ...
Lung Non-Small ...
Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Cone-Beam Compu...
Conventional Su...
Laser Ablation
18 Years - M.D. Anderson Cancer Center View CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer NCT03546361 Lung Non-Small ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Autologous Dend...
Pembrolizumab
18 Years - Jonsson Comprehensive Cancer Center View A Nurse-Led Intervention for Fear of Progression in Advanced Cancer NCT04819997 Advanced Lung C...
Metastatic Mali...
Stage III Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
Stage IIIC Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Educational Int...
- City of Hope Medical Center View Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer NCT05045404 Metastatic Lung...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Poziotinib Hydr...
1429757-68-5, H...
18 Years - M.D. Anderson Cancer Center View